Financial Performance - Q4 2024 system-wide sales increased by 9%, up from 8% in Q3 2024[13] - Q4 2024 comp sales increased by 6%, up from 4% in Q3 2024[13] - Q4 2024 revenue from continuing operations increased by 14%, up from 10% in Q3 2024[13] - 2024 revenue from continuing operations was $51.9 million, a 10% increase compared to $47.0 million in 2023[35] Operational Metrics - The Joint Corp treated 1.9 million unique patients in 2024, up from 1.7 million in 2023[25] - The Joint Corp had 957,000 new patients in 2024, compared to 932,000 in 2023[25] - There were 14.7 million adjustments in 2024, up from 13.6 million in 2023[25] - 36% of new patients in 2024 were new to chiropractic[25] - 85% of system-wide gross sales in 2024 were from monthly memberships, consistent with 2023[25] 2025 Guidance - The Joint Corp projects system-wide sales between $550 million and $570 million for 2025[36] - The Joint Corp anticipates mid-single-digit system-wide comp sales growth for clinics open 13 months or more in 2025[36] - The Joint Corp estimates consolidated Adjusted EBITDA between $10.0 million and $11.5 million for 2025[36]